Select regions whose content you would like to see
The UK might be allowed to participate in the EU's science and innovation research funding programme despite leaving the EU. 14 Jun 2018
Manufacturers of connected cars and medical devices will be among the businesses able to obtain an EU-wide certificate that their products conform to cybersecurity standards under new laws that have been proposed. 08 Jun 2018
Companies that incur expenditure on research and development (R&D) may be able to claim enhanced UK corporation tax relief. Small or medium sized enterprises (SMEs) may be able to obtain an enhanced 230% deduction or, if loss making, a payable tax credit. ...
This guide was updated in May 2017
This guide provides an outline of the UK's patent box regime for the taxation of intellectual property (IP) as it applies to companies and IP within the regime before 1 July 2016.
The use of equity incentive arrangements is well recognised within the telecoms industry.
This guide was last updated in November 2016.
This guide was last updated in August 2011.
Drugs manufacturers in Ireland can expect fewer regulatory inspections of their manufacturing practices after a US regulator announced it is happy to rely on conclusions reached by Ireland's Health Products Regulatory Authority (HPRA), a life sciences expert... 01 Jun 2018
Generic drugs companies will be free to manufacture new products for non-EU markets during the period that supplementary protection certificates (SPCs) are in force under proposed new EU laws. 29 May 2018
Join My Out-Law
Already signed up to My Out-Law?
The current market can be both challenging and interesting for companies in the Life Sciences sector. We are committed to leveraging our knowledge of the law to create a business tool to provide you with strategic advice and support. We are able to identify and capitalise on new opportunities, defend and open up markets and help you diversify so you achieve your commercial objectives.
More about Life Sciences
Partner - Head of IP & Life Sciences